Povidone-Iodine
Active ingredient · 6 therapeutic classes
Sold as sterile · Betadine · Aplicare · PVP Iodine · MediChoice PVP
- Drug class
- Other Antiinfectives and Antiseptics
- Availability
- Over-the-counter
- Routes
- Topical, Cutaneous, Nasal
- Markets covered
- 2
- Products on record
- 43
- FDA reports (12 mo)
- 254
Overview
Plain-language summary, compiled from the cited regulatory records
Povidone-iodine is an antiseptic agent classified as an iodine product [1]. It is approved for use as a first-aid treatment to help prevent infection in minor cuts, scrapes, and burns [1].
This active ingredient is available under various brand names, including Betadine and Aplicare [1]. In the past 12 months, there have been 254 adverse event reports associated with povidone-iodine [2]. The most frequently reported reactions include off-label use, rash, the product being ineffective, use in unapproved indications, and confusional state [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 33 | February 25, 2026 |
| GB United Kingdom | MHRA | 10 | May 15, 2026 |
USUnited States· FDA
33 products
Uses
Uses First aid to help prevent infection in minor cuts scrapes burns
How to take
GBUnited Kingdom· MHRA
10 products
Uses
Betadine Throat Spray is indicated for oral hygiene and acute treatment of oromucosal and pharyngeal infections of viral, bacterial or fungal origin such as: Sore throat (pharyngitis).
How to take
Sources & citations
- [1]FDA DailyMed · 00002127-02bc-4c… · revised January 2, 2025 [PDF]
- [2]MHRA (UK) · PL584420002 · revised November 1, 2024
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.